5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide

C89H61BBrN8O6S4- — CID 165088307

IUPAC5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide
SMILESC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CC(=O)Nc1nc2ccc(-c3cnc4scc(C(=O)NC5CCCCC5)c4c3)cc2s1.CC(=O)Nc1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2s1.O=C(NC1CCCCC1)c1csc2ncc(Br)cc12.[C-]#CC#CC#CC#CC#CC#CC#CC#CC#C
InChIInChI=1S/C23H22N4O2S2.C19H4.C18H.C15H19BN2O3S.C14H15BrN2OS/c1-13(28)25-23-27-19-8-7-14(10-20(19)31-23)15-9-17-18(12-30-22(17)24-11-15)21(29)26-16-5-3-2-4-6-16;1-3-5-7-9-11-13-15-17-19-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-18-16-14-12-10-8-6-4-2;1-9(19)17-13-18-11-7-6-10(8-12(11)22-13)16-20-14(2,3)15(4,5)21-16;15-9-6-11-12(8-19-14(11)16-7-9)13(18)17-10-4-2-1-3-5-10/h7-12,16H,2-6H2,1H3,(H,26,29)(H,25,27,28);1H,2H3;1H;6-8H,1-5H3,(H,17,18,19);6-8,10H,1-5H2,(H,17,18)/q;;-1;;
InChIKeyWGQIOWHUALNNMD-UHFFFAOYSA-N
MW1557.50 g/mol
LogP13.17
Rot. Bonds8

About 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide

5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide (PubChem CID 165088307) has the molecular formula C89H61BBrN8O6S4- and a molecular weight of 1557.50 g/mol. Its IUPAC name is 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide.

Molecular Properties

Compound Name5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide
PubChem CID165088307
Molecular FormulaC89H61BBrN8O6S4-
Molecular Weight1557.50 g/mol
Exact Mass1555.29
IUPAC Name5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide
SMILESC#CC#CC#CC#CC#CC#CC#CC#CC#CC.CC(=O)Nc1nc2ccc(-c3cnc4scc(C(=O)NC5CCCCC5)c4c3)cc2s1.CC(=O)Nc1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2s1.O=C(NC1CCCCC1)c1csc2ncc(Br)cc12.[C-]#CC#CC#CC#CC#CC#CC#CC#CC#C
InChIInChI=1S/C23H22N4O2S2.C19H4.C18H.C15H19BN2O3S.C14H15BrN2OS/c1-13(28)25-23-27-19-8-7-14(10-20(19)31-23)15-9-17-18(12-30-22(17)24-11-15)21(29)26-16-5-3-2-4-6-16;1-3-5-7-9-11-13-15-17-19-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-18-16-14-12-10-8-6-4-2;1-9(19)17-13-18-11-7-6-10(8-12(11)22-13)16-20-14(2,3)15(4,5)21-16;15-9-6-11-12(8-19-14(11)16-7-9)13(18)17-10-4-2-1-3-5-10/h7-12,16H,2-6H2,1H3,(H,26,29)(H,25,27,28);1H,2H3;1H;6-8H,1-5H3,(H,17,18,19);6-8,10H,1-5H2,(H,17,18)/q;;-1;;
InChIKeyWGQIOWHUALNNMD-UHFFFAOYSA-N
XLogP13.17
TPSA186.42 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds8
Heavy Atoms109
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001557.50
LogP ≤ 513.17
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide?
The IUPAC name of 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide (CID 165088307) is 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide.
What is the SMILES notation for 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide?
The canonical SMILES for 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide is C#CC#CC#CC#CC#CC#CC#CC#CC#CC.CC(=O)Nc1nc2ccc(-c3cnc4scc(C(=O)NC5CCCCC5)c4c3)cc2s1.CC(=O)Nc1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2s1.O=C(NC1CCCCC1)c1csc2ncc(Br)cc12.[C-]#CC#CC#CC#CC#CC#CC#CC#CC#C.
What is the InChIKey of 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide?
The InChIKey is WGQIOWHUALNNMD-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H22N4O2S2.C19H4.C18H.C15H19BN2O3S.C14H15BrN2OS/c1-13(28)25-23-27-19-8-7-14(10-20(19)31-23)15-9-17-18(12-30-22(17)24-11-15)21(29)26-16-5-3-2-4-6-16;1-3-5-7-9-11-13-15-17-19-18-16-14-12-10-8-6-4-2;1-3-5-7-9-11-13-15-17-18-16-14-12-10-8-6-4-2;1-9(19)17-13-18-11-7-6-10(8-12(11)22-13)16-20-14(2,3)15(4,5)21-16;15-9-6-11-12(8-19-14(11)16-7-9)13(18)17-10-4-2-1-3-5-10/h7-12,16H,2-6H2,1H3,(H,26,29)(H,25,27,28);1H,2H3;1H;6-8H,1-5H3,(H,17,18,19);6-8,10H,1-5H2,(H,17,18)/q;;-1;;.
What are the key properties of 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide?
5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide has a molecular weight of 1557.50 g/mol, XLogP of 13.17, 8 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;5-bromo-N-cyclohexylthieno[2,3-b]pyridine-3-carboxamide;nonadeca-1,3,5,7,9,11,13,15,17-nonayne;octadeca-1,3,5,7,9,11,13,15,17-nonayne;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide is sourced from PubChem (CID 165088307), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).